| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.005 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |